Literature DB >> 15121630

Stage IIIC small cell carcinoma of the ovary: survival with conservative surgery and chemotherapy.

Sarosh Rana1, Bretta K Warren, S Diane Yamada.   

Abstract

BACKGROUND: Small cell carcinoma of the ovary is an aggressive tumor primarily affecting young women. Despite adjuvant therapy, the majority of patients described in the literature have fared poorly, even when the disease is diagnosed at an early stage. CASE: A 19-year-old nulligravida with small cell carcinoma of the left ovary underwent conservative surgery with staging and was found to have stage IIIC disease. She received multiagent chemotherapy with vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide and is alive and doing well more than 2 years after completion of her therapy, with no evidence of disease.
CONCLUSION: In young patients who desire future fertility, conservative surgery followed by aggressive multiagent chemotherapy may be an effective treatment regimen and warrants further consideration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121630     DOI: 10.1097/01.AOG.0000124996.56880.d9

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  Successful reproductive outcome following treatment of advanced small cell carcinoma of the ovary.

Authors:  N H Walker; M Sabanli; P H Sykes; P Russell; D Perez
Journal:  Gynecol Oncol Case Rep       Date:  2012-06-26

Review 2.  Dose-dense and dose-intense chemotherapy for small cell ovarian cancer: 2 cases and review of literature.

Authors:  Raj Kumar Shrimali; Peter Denzil Correa; Nick S Reed
Journal:  Med Oncol       Date:  2010-04-02       Impact factor: 3.064

3.  Establishment and characterization of a human ovarian small cell carcinoma, hypercalcemic type, cell line (OS-1) secreting PTH, PthrP and ACTH--special reference to the susceptibility of anti-cancer drugs.

Authors:  Satoshi Ohi; Shigeki Niimi; Naoya Okada; Kyosuke Yamada; Toshiaki Tachibana; Hisashi Hashimoto; Masako Nakajima; Mitsuru Yasuda; Tadao Tanaka; Kahei Sato; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2004-12       Impact factor: 4.174

4.  Small Cell Ovarian Carcinomas - Characterisation of Two Rare Tumor Entities.

Authors:  K Münstedt; R Estel; T Dreyer; A Kurata; A Benz
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-07       Impact factor: 2.915

5.  Small cell ovarian carcinoma: genomic stability and responsiveness to therapeutics.

Authors:  Lisa F Gamwell; Karen Gambaro; Maria Merziotis; Colleen Crane; Suzanna L Arcand; Valerie Bourada; Christopher Davis; Jeremy A Squire; David G Huntsman; Patricia N Tonin; Barbara C Vanderhyden
Journal:  Orphanet J Rare Dis       Date:  2013-02-21       Impact factor: 4.123

6.  Small cell ovarian cancer in adolescents: report of two cases and review of the literature.

Authors:  M Rovithi; A G Pallis; A Kalykaki; E Lagoudaki; L Giannikaki; E N Stathopoulos; K Relakis; V Georgoulias
Journal:  Case Rep Med       Date:  2011-05-31

Review 7.  Primary ovarian small cell carcinoma of pulmonary type with coexisting endometrial carcinoma in a breast cancer patient receiving tamoxifen: A case report and literature review.

Authors:  Lei Yin; Jianning Li; Yunhai Wei; Dejian Ma; Yamei Sun; Yanlai Sun
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.